Overview
On May 22, 2024, Australia identified its first confirmed H5 avian influenza case at a poultry farm in Meredith, Victoria. This identification was the result of a rapid diagnostic and analysis process undertaken by scientists at the Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australian Centre for Disease Preparedness (ACDP) in Geelong. The process involved multiple diagnostic stages, from initial sample receipt to full genomic sequencing, culminating in the official confirmation of the H5N1 strain.
Research Context
Australia has maintained a bird flu-free status, particularly concerning H5 and H7 highly pathogenic avian influenza (HPAI), for decades. The emergence of H5N1 in other parts of the world, specifically the current global panzootic which has affected birds, mammals, and, in rare instances, humans, has underscored the importance of robust diagnostic and preparedness capabilities. CSIRO's ACDP holds the status of an international reference laboratory for avian influenza, recognized by both the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization of the United Nations (FAO).
Approach
The diagnostic response initiated on May 21, 2024, following the delivery of suspected avian influenza samples from the Victorian poultry farm to ACDP. The overall process involved several key steps:
- Sample Receipt and Triage: Samples were received at the ACDP facility in Geelong.
- Initial PCR Screening: Scientists employed a real-time polymerase chain reaction (PCR) test targeting the influenza A virus. This initial test yielded a positive result, confirming the presence of an influenza A virus.
- Subtype Identification: Following the positive influenza A result, a specific PCR test for the H5 subtype was conducted, which also returned a positive result, indicating the presence of an H5 avian influenza virus.
- Confirmation of Pathogenicity: Due to the positive H5 result, the samples were transferred to a high-containment laboratory. Further testing was conducted to determine the pathogenicity of the virus.
- Whole-Genome Sequencing: Concurrently with pathogenicity testing, scientists initiated whole-genome sequencing of the virus. This involved isolating the virus, extracting its genetic material, and using advanced sequencing technologies. This step aimed to determine the exact strain of the virus, its genetic makeup, and potential linkages to global outbreaks.
This multi-stage process, leveraging established protocols and specialized laboratory infrastructure, was designed for rapid turnaround times, with initial diagnostic results available within hours of sample receipt and full genomic data available within 24 hours.
Findings
The investigations conducted by CSIRO scientists at the ACDP confirmed the following:
- Presence of Influenza A: Initial PCR tests confirmed the presence of an influenza A virus in the submitted samples.
- H5 Subtype Identification: Subsequent specific PCR testing identified the H5 subtype, indicating an H5 avian influenza virus.
- High Pathogenicity: Further testing confirmed the highly pathogenic nature of the H5 virus.
- Specific Strain Identification: Whole-genome sequencing identified the specific strain as H5N1. The sequencing results further indicated that this H5N1 strain is closely related to viruses circulating in poultry in Southeast Asia.
Why This Matters
The confirmation of Australia's first H5 avian influenza case has significant implications for biosecurity and public health preparedness. The rapid identification of the H5N1 strain, within hours of samples arriving at ACDP, enabled swift communication to government and industry stakeholders, allowing for immediate implementation of control measures. This rapid diagnostic capacity is crucial for containing outbreaks and mitigating economic impacts on the poultry industry, as well as informing national biosecurity responses to prevent broader spread and potential risks to other animal populations. The identification of a strain related to those in Southeast Asia provides epidemiological context for understanding the virus's likely origin and transmission pathways.
Potential Applications
The established rapid diagnostic and genomic sequencing capabilities demonstrated during this event have ongoing applications in Australia's biosecurity framework:
- Enhanced Surveillance: The ability to quickly identify and characterize avian influenza viruses supports ongoing surveillance efforts to detect new incursions or changes in circulating strains.
- Vaccine Development and Preparedness: Detailed genomic data, such as that obtained for the H5N1 strain, can inform decisions regarding potential vaccine development strategies or the selection of appropriate vaccine candidates, should they be required in the future.
- Outbreak Response Protocols: The successful execution of a rapid diagnostic pipeline reinforces and refines existing outbreak response protocols, ensuring that future biosecurity threats can be addressed with similar efficiency.